2025年全球扁平疣治療市場報告

預計未來幾年睫狀體平坦部炎治療市場規模將強勁成長。 2029年，該市場規模將成長至9,204.8億美元，複合年成長率為7.7%。預測期內的預期成長歸因於生物療法的普及、自體免疫疾病盛行率的上升、對兒童眼科護理的日益重視、醫療保險覆蓋範圍的擴大以及對個性化治療方法日益成長的需求。預計在此期間的主要趨勢包括轉向類固醇緩釋治療方法、將遠距眼科技術融入患者管理、長效藥物植入的開發、生物相似藥在偏好中的應用以及對聯合治療策略的日益青睞。

鱗狀蜂窩性組織炎盛行率的不斷上升預計將推動睫狀體平坦部炎治療市場的成長。鱗狀蜂窩性組織炎是一種特發性中間葡萄膜炎，可導致玻璃體和周邊視網膜發炎，最常見於 15 至 40 歲的人。盛行率的上升與人們所認知的提高和診斷技術的進步有關，從而可以更早、更準確地發現。鱗狀蜂窩性組織炎的治療對於控制眼部發炎、保護視力和預防嚴重併發症至關重要。這些治療方法包括皮質類固醇和免疫抑制劑，有助於長期眼部健康和改善生活品質。例如，根據美國醫學雜誌《Mega Journal of Case Reports》於 2025 年 2 月發表的病例報告，中間葡萄膜炎的發生率為每 100,000 人口 1.4 至 2 例，其中副鱗狀蜂窩性組織炎佔這些病例的 70%。發病率的增加促進了治療市場的擴大。

睫狀體平坦部炎治療領域的公司正專注於開發包括雙特異性抗體在內的先進治療方法，以改善發炎控制並減少全身副作用。雙特異性抗體旨在同時結合兩種不同的抗原，從而實現更有針對性和更有效的治療。 2023 年 10 月，美國生物技術公司基因泰克 (Genentech) 的 Vabysmo (faricimab-svoa) 獲得 FDA 批准，用於治療視網膜靜脈阻塞，領先該藥物已核准用於治療老齡化黃斑部病變和糖尿病性黃斑部水腫。 Vabysmo 是首個核准用於眼科的雙特異性抗體，同時核准血管生成素 2 (Ang-2) 和血管內皮生長因子 A (VEGF-A)。這種雙重作用方法有助於控制發炎和血管滲漏，目前正在研究用於治療中間葡萄膜炎，包括睫狀體平坦部炎，這種疾病的視網膜周邊持續性發炎需要有針對性的干涉。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球睫狀體扁平苔癬治療：PESTEL 分析（政治、社會、技術、環境、法律、促進因素和限制因素）
• 最終用途產業分析
• 全球扁平疣治療市場：成長率分析
• 全球扁平疣治療市場表現：規模與成長，2019-2024 年
• 全球扁平疣治療市場預測：規模與成長，2024-2029 年，2034 年
• 全球睫狀體扁平苔癬治療：總目標市場（TAM）

第6章市場區隔

• 全球扁平疣治療市場（依治療方法、績效及預測），2019-2024 年、2024-2029 年、2034 年
• 皮質類固醇
• 非類固醇消炎劑（NSAID）
• 外科手術
• 冷凍療法
• 免疫調節療法
• 其他治療方法
• 全球睫狀體扁平苔癬治療市場（依診斷、表現及預測），2019-2024 年、2024-2029 年、2034 年
• 血液檢查
• X光
• 磁振造影（MRI）
• 其他診斷
• 全球睫狀體扁平苔癬治療市場：依給藥途徑、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 口服
• 靜脈
• 其他給藥途徑
• 全球睫狀體扁平苔癬治療市場：依通路、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 醫院藥房
• 零售藥局
• 網路藥局
• 全球扁平疣治療市場：按最終用戶、績效和預測，2019-2024 年、2024-2029 年、2034 年
• 診所
• 醫院
• 其他最終用戶
• 全球睫狀體扁平苔癬治療市場，依皮質類固醇類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
• 局部固醇
• 眼周注射皮質類固醇
• 玻璃體內皮質類固醇植入
• 全身性皮質類固醇
• 全球扁平疣治療市場按非類固醇消炎劑（NSAID）類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
• 口服非類固醇消炎劑（NSAID）
• 局部非類固醇消炎劑（NSAID）
• 注射非類固醇消炎劑（NSAID）
• 全球睫狀體扁平苔癬治療市場，依手術類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
• 玻璃體切除手術
• 白內障手術
• 青光眼手術
• 全球睫狀體扁平苔癬治療市場冷凍療法細分市場（按類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
• 經鞏膜冷凍療法
• 體內冷凍療法
• 全球睫狀體扁平苔癬治療市場按免疫調節療法類型、表現和預測細分，2019-2024 年、2024-2029 年、2034 年
• 抗代謝藥
• Calcineurin抑制劑
• 生物製藥
• 全球睫狀體扁平苔癬治療市場，依其他治療方法細分，按類型、績效和預測，2019-2024 年、2024-2029 年、2034 年
• 抗生素
• 抗病毒藥物
• 雷射治療

第7章 區域和國家分析

• 全球扁平疣治療市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 全球扁平疣治療市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

• 睫狀體扁平苔癬治療市場：競爭格局
• 睫狀體扁平苔癬治療市場：公司簡介
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

• Novartis AG
• EyePoint Pharmaceuticals Inc.
• Medtronic plc
• Eli Lilly and Company
• Teva Pharmaceutical Industries Ltd.
• Quantum Cryogenics Ltd.
• Zimmer MedizinSysteme GmbH
• Sun Pharmaceutical Industries Ltd.
• Hologic Inc.
• Aurobindo Pharma Limited
• Santen Pharmaceutical Co. Ltd.
• CooperSurgical Inc.
• AtriCure Inc.
• Alimera Sciences Inc.
• Clearside Biomedical Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

• 2029 年睫狀體扁平苔癬治療市場：提供新機會的國家
• 2029 年睫狀體扁平苔癬治療市場：細分領域帶來新機會
• 2029 年睫狀體扁平苔癬治療市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第36章 附錄

Pars planitis treatment involves both medical and surgical approaches designed to manage this chronic form of intermediate uveitis, which affects the pars plana region of the eye and may lead to inflammation and potential vision loss. The main objective of treatment is to control ocular inflammation, prevent complications such as macular edema or retinal detachment, and maintain visual function.

The primary treatment options for pars planitis include corticosteroids, non-steroidal anti-inflammatory drugs (NSAIDs), surgical procedures, cryotherapy, immunomodulatory therapies, and others. Corticosteroids are anti-inflammatory drugs that mimic adrenal gland hormones to reduce swelling, suppress immune activity, and treat inflammation-related conditions. Diagnostic methods include blood tests, X-rays, magnetic resonance imaging (MRI), and others, with treatments administered via oral, intravenous, and other routes. These treatments are distributed through various channels, such as hospital pharmacies, retail pharmacies, and online pharmacies, and are used by a range of end users including hospitals, clinics, and other healthcare facilities.

The pars planitis treatment market research report is one of a series of new reports from The Business Research Company that provides pars planitis treatment market statistics, including the pars planitis treatment industry's global market size, regional shares, competitors with an pars planitis treatment market share, detailed pars planitis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the pars planitis treatment industry. This pars planitis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pars planitis treatment market size has grown strongly in recent years. It will grow from $632.88 billion in 2024 to $683.54 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth during the historic period can be attributed to increased awareness of autoimmune eye disorders, a rising incidence of uveitis in pediatric populations, improved access to ophthalmic care, broader use of immunosuppressive therapies, and heightened patient awareness regarding the importance of early intervention.

The pars planitis treatment market size is expected to see strong growth in the next few years. It will grow to $920.48 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth anticipated in the forecast period can be attributed to the increasing adoption of biologic therapies, a rising prevalence of autoimmune diseases, heightened emphasis on pediatric eye care, broader health insurance coverage, and growing demand for personalized treatment approaches. Key trends expected during this period include a shift toward steroid-sparing treatment options, the integration of teleophthalmology in patient management, the development of long-acting drug implants, the use of biosimilars in therapy, and a rising preference for combination treatment strategies.

The rising prevalence of pars planitis is expected to drive the growth of the pars planitis treatment market. Pars planitis is an idiopathic type of intermediate uveitis that causes inflammation in the vitreous and peripheral retina, most commonly affecting people between the ages of 15 and 40. The increase in prevalence is linked to improved awareness and advancements in diagnostic technology, allowing for earlier and more accurate detection. Treatments for pars planitis are essential for managing ocular inflammation, which helps preserve vision and prevent serious complications. These therapies, which include corticosteroids and immunosuppressants, contribute to better long-term eye health and quality of life. As an example, a case report published in February 2025 by the Mega Journal of Case Reports, a U.S.-based medical journal, noted that intermediate uveitis occurs at a rate of 1.4 to 2 cases per 100,000 people, with pars planitis making up 70% of those cases. This increasing occurrence is contributing to the expansion of the treatment market.

Companies in the pars planitis treatment space are focusing on developing advanced therapies, including bispecific antibodies, to improve inflammation control and reduce systemic side effects. Bispecific antibodies are engineered to bind to two different antigens at once, allowing for more targeted and effective treatment. In October 2023, Genentech Inc., a biotechnology company based in the U.S., received FDA approval for Vabysmo (faricimab-svoa) for treating retinal vein occlusion, in addition to its earlier approvals for age-related macular degeneration and diabetic macular edema. Vabysmo is the first bispecific antibody approved for ophthalmic use, targeting both Angiopoietin-2 (Ang-2) and vascular endothelial growth factor A (VEGF-A). This dual-action approach helps control inflammation and vascular leakage and is being investigated for treating intermediate uveitis, including pars planitis, where persistent inflammation in the retinal periphery requires precise intervention.

In March 2022, Bausch + Lomb, a healthcare company headquartered in Canada, entered into a partnership with Clearside Biomedical Inc. to commercialize XIPERE in the U.S. for treating macular edema linked to uveitis. The goal of the partnership is to broaden access to XIPERE, which is the first FDA-approved therapy administered via suprachoroidal injection. This delivery method offers a targeted and effective option for the estimated 300,000 Americans affected by uveitis. Clearside Biomedical Inc., based in the U.S., contributes to pars planitis treatment through its involvement with XIPERE.

Major players in the pars planitis treatment market are Johnson & Johnson, Merck & Co Inc., AbbVie Inc., Bayer AG, AstraZeneca plc, Novartis AG, EyePoint Pharmaceuticals Inc., Medtronic plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Quantum Cryogenics Ltd., Zimmer MedizinSysteme GmbH, Sun Pharmaceutical Industries Ltd., Hologic Inc., Aurobindo Pharma Limited, Santen Pharmaceutical Co. Ltd., CooperSurgical Inc., AtriCure Inc., Alimera Sciences Inc., and Clearside Biomedical Inc.

North America was the largest region in the pars planitis treatment market in 2024. The regions covered in pars planitis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pars planitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pars planitis treatment market consists of revenues earned by entities by providing services such as diagnosis, pharmacological therapies, surgical interventions, and supportive care management. The market value includes the value of related goods sold by the service provider or included within the service offering. The pars planitis treatment market also includes sales of immunosuppressants, intraocular steroid implants, surgical equipment, and diagnostic tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pars Planitis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pars planitis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pars planitis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pars planitis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment: Corticosteroid; Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Surgery; Cryotherapy; Immunomodulatory Therapy; Other Treatments
• 2) By Diagnosis: Blood Tests; X-ray; Magnetic Resonance Imaging (MRI); Other Diagnosis
• 3) By Route Of Administration: Oral; Intravenous; Other Routes Of Administration
• 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
• 5) By End-User: Clinic; Hospital; Other End-Users
• Subsegments:
• 1) By Corticosteroid: Topical Corticosteroids; Periocular Corticosteroid Injections; Intravitreal Corticosteroid Implants; Systemic Corticosteroids
• 2) By Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Oral Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Topical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Injectable Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
• 3) By Surgery: Pars Plana Vitrectomy; Cataract Surgery; Glaucoma Surgery
• 4) By Cryotherapy: Trans-scleral Cryotherapy; Endocryotherapy
• 5) By Immunomodulatory Therapy: Antimetabolites; Calcineurin Inhibitors; Biologic Agents
• 6) By Other Treatments: Antibiotics; Antivirals; Laser therapy
• Companies Mentioned: Johnson & Johnson; Merck & Co Inc.; AbbVie Inc.; Bayer AG; AstraZeneca plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pars Planitis Treatment Market Characteristics

3. Pars Planitis Treatment Market Trends And Strategies

4. Pars Planitis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Pars Planitis Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pars Planitis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pars Planitis Treatment Market Growth Rate Analysis
• 5.4. Global Pars Planitis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pars Planitis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pars Planitis Treatment Total Addressable Market (TAM)

6. Pars Planitis Treatment Market Segmentation

• 6.1. Global Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Corticosteroid
• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
• Surgery
• Cryotherapy
• Immunomodulatory Therapy
• Other Treatments
• 6.2. Global Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Tests
• X-ray
• Magnetic Resonance Imaging (MRI)
• Other Diagnosis
• 6.3. Global Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Intravenous
• Other Routes Of Administration
• 6.4. Global Pars Planitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• 6.5. Global Pars Planitis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinic
• Hospital
• Other End-Users
• 6.6. Global Pars Planitis Treatment Market, Sub-Segmentation Of Corticosteroid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Corticosteroids
• Periocular Corticosteroid Injections
• Intravitreal Corticosteroid Implants
• Systemic Corticosteroids
• 6.7. Global Pars Planitis Treatment Market, Sub-Segmentation Of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
• Topical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
• Injectable Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
• 6.8. Global Pars Planitis Treatment Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pars Plana Vitrectomy
• Cataract Surgery
• Glaucoma Surgery
• 6.9. Global Pars Planitis Treatment Market, Sub-Segmentation Of Cryotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Trans-scleral Cryotherapy
• Endocryotherapy
• 6.10. Global Pars Planitis Treatment Market, Sub-Segmentation Of Immunomodulatory Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antimetabolites
• Calcineurin Inhibitors
• Biologic Agents
• 6.11. Global Pars Planitis Treatment Market, Sub-Segmentation Of Other Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibiotics
• Antivirals
• Laser therapy

7. Pars Planitis Treatment Market Regional And Country Analysis

• 7.1. Global Pars Planitis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pars Planitis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pars Planitis Treatment Market

• 8.1. Asia-Pacific Pars Planitis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pars Planitis Treatment Market

• 9.1. China Pars Planitis Treatment Market Overview
• 9.2. China Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pars Planitis Treatment Market

• 10.1. India Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pars Planitis Treatment Market

• 11.1. Japan Pars Planitis Treatment Market Overview
• 11.2. Japan Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pars Planitis Treatment Market

• 12.1. Australia Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pars Planitis Treatment Market

• 13.1. Indonesia Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pars Planitis Treatment Market

• 14.1. South Korea Pars Planitis Treatment Market Overview
• 14.2. South Korea Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pars Planitis Treatment Market

• 15.1. Western Europe Pars Planitis Treatment Market Overview
• 15.2. Western Europe Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pars Planitis Treatment Market

• 16.1. UK Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pars Planitis Treatment Market

• 17.1. Germany Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pars Planitis Treatment Market

• 18.1. France Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pars Planitis Treatment Market

• 19.1. Italy Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pars Planitis Treatment Market

• 20.1. Spain Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pars Planitis Treatment Market

• 21.1. Eastern Europe Pars Planitis Treatment Market Overview
• 21.2. Eastern Europe Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pars Planitis Treatment Market

• 22.1. Russia Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pars Planitis Treatment Market

• 23.1. North America Pars Planitis Treatment Market Overview
• 23.2. North America Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pars Planitis Treatment Market

• 24.1. USA Pars Planitis Treatment Market Overview
• 24.2. USA Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pars Planitis Treatment Market

• 25.1. Canada Pars Planitis Treatment Market Overview
• 25.2. Canada Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pars Planitis Treatment Market

• 26.1. South America Pars Planitis Treatment Market Overview
• 26.2. South America Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pars Planitis Treatment Market

• 27.1. Brazil Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pars Planitis Treatment Market

• 28.1. Middle East Pars Planitis Treatment Market Overview
• 28.2. Middle East Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pars Planitis Treatment Market

• 29.1. Africa Pars Planitis Treatment Market Overview
• 29.2. Africa Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pars Planitis Treatment Market Competitive Landscape And Company Profiles

• 30.1. Pars Planitis Treatment Market Competitive Landscape
• 30.2. Pars Planitis Treatment Market Company Profiles
  • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

31. Pars Planitis Treatment Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. EyePoint Pharmaceuticals Inc.
• 31.3. Medtronic plc
• 31.4. Eli Lilly and Company
• 31.5. Teva Pharmaceutical Industries Ltd.
• 31.6. Quantum Cryogenics Ltd.
• 31.7. Zimmer MedizinSysteme GmbH
• 31.8. Sun Pharmaceutical Industries Ltd.
• 31.9. Hologic Inc.
• 31.10. Aurobindo Pharma Limited
• 31.11. Santen Pharmaceutical Co. Ltd.
• 31.12. CooperSurgical Inc.
• 31.13. AtriCure Inc.
• 31.14. Alimera Sciences Inc.
• 31.15. Clearside Biomedical Inc.

32. Global Pars Planitis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pars Planitis Treatment Market

34. Recent Developments In The Pars Planitis Treatment Market

35. Pars Planitis Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Pars Planitis Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pars Planitis Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pars Planitis Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer